BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21824126)

  • 1. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients.
    Binus AM; Qureshi AA; Li VW; Winterfield LS
    Br J Dermatol; 2011 Dec; 165(6):1244-50. PubMed ID: 21824126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
    Menachem Y; Gotsman I
    Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
    Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
    Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases].
    Duarte AF; Nogueira A; Lisboa C; Azevedo F
    Dermatol Online J; 2009 Jul; 15(7):3. PubMed ID: 19903431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pyoderma gangrenosum: a report of 15 cases and review of the literature].
    Suárez-Pérez JA; Herrera-Acosta E; López-Navarro N; Vilchez-Márquez F; Prieto JD; Bosch RJ; Herrera E
    Actas Dermosifiliogr; 2012 Mar; 103(2):120-6. PubMed ID: 21782147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor prognosis of arthritis-associated pyoderma gangrenosum.
    Charles CA; Bialy TL; Falabella AF; Eaglstein WH; Kerdel FA; Kirsner RS
    Arch Dermatol; 2004 Jul; 140(7):861-4. PubMed ID: 15262699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pyoderma gangrenosum: case series].
    Richetta AG; Maiani E; Carboni V; Carlomagno V; Cimillo M; Mattozzi C; Calvieri S
    Clin Ter; 2007; 158(4):325-9. PubMed ID: 17953284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum: uncommon presentations.
    Ahmadi S; Powell FC
    Clin Dermatol; 2005; 23(6):612-20. PubMed ID: 16325070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyoderma gangrenosum--a review of 24 cases observed over 10 years.
    Pereira N; Brites MM; Gonçalo M; Tellechea O; Figueiredo A
    Int J Dermatol; 2013 Aug; 52(8):938-45. PubMed ID: 23676016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.
    Ashchyan HJ; Butler DC; Nelson CA; Noe MH; Tsiaras WG; Lockwood SJ; James WD; Micheletti RG; Rosenbach M; Mostaghimi A
    JAMA Dermatol; 2018 Apr; 154(4):409-413. PubMed ID: 29450453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features.
    Vidal D; Puig L; Gilaberte M; Alomar A
    J Dermatolog Treat; 2004 Jun; 15(3):146-52. PubMed ID: 15204146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parastomal pyoderma gangrenosum: clinical features and management.
    Lyon CC; Smith AJ; Beck MH; Wong GA; Griffiths CE
    J Am Acad Dermatol; 2000 Jun; 42(6):992-1002. PubMed ID: 10827402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.
    Saracino A; Kelly R; Liew D; Chong A
    Australas J Dermatol; 2011 Aug; 52(3):218-21. PubMed ID: 21834821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associated comorbidities in psoriasis and inflammatory bowel disease.
    Binus AM; Han J; Qamar AA; Mody EA; Holt EW; Qureshi AA
    J Eur Acad Dermatol Venereol; 2012 May; 26(5):644-50. PubMed ID: 21689167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of peristomal pyoderma gangrenosum.
    Poritz LS; Lebo MA; Bobb AD; Ardell CM; Koltun WA
    J Am Coll Surg; 2008 Feb; 206(2):311-5. PubMed ID: 18222385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyoderma gangrenosum as initial manifestation of Graves' disease.
    Livideanu C; Lipsker D; Paul C; Juillard J; Schubert B
    Clin Exp Dermatol; 2006 Sep; 31(5):659-61. PubMed ID: 16780496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyoderma gangrenosum: a report of 44 cases with follow-up.
    von den Driesch P
    Br J Dermatol; 1997 Dec; 137(6):1000-5. PubMed ID: 9470924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literature.
    Androutsakos T; Stamopoulos P; Aroni K; Hatzis G
    BMC Gastroenterol; 2015 Oct; 15():149. PubMed ID: 26502871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic work-up and treatment in patients with pyoderma gangrenosum: retrospective analysis of US insurance claims-based data.
    Shaigany S; Wong PW; Caplan A; Kim RH; Femia A
    Arch Dermatol Res; 2023 Jan; 315(1):95-99. PubMed ID: 34714405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of peristomal pyoderma gangrenosum.
    Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
    Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.